Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?

IK Delattre, FS Taccone, F Jacobs, M Hites… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The pharmacokinetic/pharmacodynamic index determining β-lactam activity is
the percentage of the dosing interval (% T) during which their free serum concentration …

Continuous and prolonged intravenous β-lactam dosing: implications for the clinical laboratory

M Grupper, JL Kuti, DP Nicolau - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Beta-lactam antibiotics serve as a cornerstone in the management of bacterial infections
because of their wide spectrum of activity and low toxicity. Since resistance rates among …

Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants

M Cohen-Wolkowiez, KM Watt, C Zhou… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Piperacillin-tazobactam is often given to infants with severe infection in spite of limited
pharmacokinetics (PK) data. We evaluated piperacillin-tazobactam PK in premature and …

Population pharmacokinetics and pharmacodynamics of extended-infusion piperacillin and tazobactam in critically ill children

K Nichols, EK Chung, CA Knoderer… - Antimicrobial agents …, 2016 - Am Soc Microbiol
The study objective was to evaluate the population pharmacokinetics and
pharmacodynamics of extended-infusion piperacillin-tazobactam in children hospitalized in …

Dosing antibiotics in neonates: review of the pharmacokinetic data

ND Rivera-Chaparro, M Cohen-Wolkowiez… - Future …, 2017 - Future Medicine
Antibiotics are often used in neonates despite the absence of relevant dosing information in
drug labels. For neonatal dosing, clinicians must extrapolate data from studies for adults and …

Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients

SC Cheatham, MR Fleming, DP Healy… - International journal of …, 2013 - Elsevier
The study objective was to evaluate steady-state pharmacokinetics and pharmacodynamics
of piperacillin and tazobactam administered by prolonged infusion in obese patients …

Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients

GC Lee, H Liou, R Yee, CF Quan, K Neldner - Clinical therapeutics, 2012 - Elsevier
Studies evaluating the outcomes of an extended-infusion (EI) piperacillin-tazobactam dosing
strategy in specific cohorts of critically ill patients are lacking. A retrospective, pre …

the pharmacodynamics of prolonged infusion β-lactams for the treatment of pseudomonas aeruginosa infections: a systematic review

AK Thabit, ALV Hobbs, OE Guzman, KM Shea - Clinical Therapeutics, 2019 - Elsevier
Purpose Pseudomonas aeruginosa is a commonly isolated nosocomial pathogen for which
treatment options are often limited for multidrug-resistant isolates. In addition to newer …

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review

GT Mah, VH Mabasa, I Chow… - Annals of …, 2012 - journals.sagepub.com
Objective: To perform a qualitative systematic review of the evidence comparing traditional
strategies against prolonged intermittent or continuous infusion strategies for piperacillin …

Time to defervescence evaluation for extended‐vs. standard‐infusion cefepime in patients with acute leukemia and febrile neutropenia

R Crawford III, NB Perkins III, DA Hobbs… - … : The Journal of …, 2022 - Wiley Online Library
Abstract Background/Objectives Febrile neutropenia (FN) occurs in up to 80% of patients
with hematologic malignancies. Evidence suggests using extended infusions (EI) of beta …